154 related articles for article (PubMed ID: 35941209)
21. Local lymph node recurrence after central neck dissection in papillary thyroid cancers: A meta analysis.
Liu H; Li Y; Mao Y
Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Nov; 136(6):481-487. PubMed ID: 31196800
[TBL] [Abstract][Full Text] [Related]
22. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
23. The utility of sentinel Lymph node biopsy in the lateral neck in papillary thyroid carcinoma.
Yan XQ; Ma ZS; Zhang ZZ; Xu D; Cai YJ; Wu ZG; Zheng ZQ; Xie BJ; Cao FL
Front Endocrinol (Lausanne); 2022; 13():937870. PubMed ID: 35957824
[TBL] [Abstract][Full Text] [Related]
24. Effect of skip metastasis to lateral neck lymph nodes on outcome of patients with papillary thyroid carcinoma.
Bertin JB; Buffet C; Leenhardt L; Menegaux F; Chereau N
Langenbecks Arch Surg; 2022 Nov; 407(7):3025-3030. PubMed ID: 35819485
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma.
Raffaelli M; De Crea C; Sessa L; Tempera SE; Belluzzi A; Lombardi CP; Bellantone R
Endocrine; 2019 Feb; 63(2):310-315. PubMed ID: 30341706
[TBL] [Abstract][Full Text] [Related]
26. Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield.
Kang IK; Park J; Bae JS; Kim JS; Kim K
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296909
[TBL] [Abstract][Full Text] [Related]
27. The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma.
Hong YR; Lee SH; Lim DJ; Kim MH; Jung CK; Chae BJ; Song BJ; Bae JS
World J Surg Oncol; 2017 Apr; 15(1):74. PubMed ID: 28376807
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients.
Lu Y; Jiang L; Chen C; Chen H; Yao Q
Medicine (Baltimore); 2020 Apr; 99(15):e19795. PubMed ID: 32282744
[TBL] [Abstract][Full Text] [Related]
29. Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.
Li J; Sun P; Huang T; Li L; He S; Ai X; Xiao H; Xue G
Eur J Surg Oncol; 2022 Jun; 48(6):1272-1279. PubMed ID: 35414404
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
[TBL] [Abstract][Full Text] [Related]
31. Indications of Superselective Neck Dissection in Patients With Lateral Node Metastasis of Papillary Thyroid Carcinoma.
Song Y; Xu G; Wang T; Zhang Y; Zhang B
Otolaryngol Head Neck Surg; 2022 May; 166(5):832-839. PubMed ID: 34488520
[TBL] [Abstract][Full Text] [Related]
32. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
33. Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma.
Zhan L; Feng HF; Yu XZ; Li LR; Song JL; Tu Y; Yuan JP; Chen C; Sun SR
BMC Surg; 2022 Jun; 22(1):235. PubMed ID: 35725426
[TBL] [Abstract][Full Text] [Related]
34. Occult contralateral central neck metastasis in papillary thyroid carcinoma with preoperatively documented ipsilateral lateral neck metastasis.
Back K; Choe JH; Kim JS; Kim JH
Eur J Surg Oncol; 2021 Jun; 47(6):1339-1345. PubMed ID: 33744024
[TBL] [Abstract][Full Text] [Related]
35. Surgical indications for upper mediastinal dissection by sternotomy in patients with papillary thyroid carcinoma.
Moritani S; Takenobu M; Yasunaga M; Kawamoto K; Fujii T; Ishida Y; Kitano H
Endocr J; 2022 Oct; 69(10):1245-1251. PubMed ID: 35650025
[TBL] [Abstract][Full Text] [Related]
36. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
38. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
[TBL] [Abstract][Full Text] [Related]
39. The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer.
Lindfors H; Ihre Lundgren C; Zedenius J; Juhlin CC; Shabo I
World J Surg; 2021 Jul; 45(7):2155-2164. PubMed ID: 33825961
[TBL] [Abstract][Full Text] [Related]
40. Histopathological Characteristics of N1b Papillary Thyroid Carcinoma are Associated with Risk of Recurrence.
Carmel Neiderman NN; Duek I; Kuzmenko B; Ringel B; Warshavsky A; Muhanna N; Horowitz G; Fliss DM
World J Surg; 2022 Aug; 46(8):1917-1925. PubMed ID: 35543736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]